Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. (Q53270093)

12 May 2018

title

Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. (English)

1 reference

12 May 2018

1 reference

1 reference

3

Arto Mannermaa

1 reference

12 May 2018

7

Hilkka Soininen

1 reference

12 May 2018

Mia Pirskanen

1

1 reference

12 May 2018

Mikko Hiltunen

2

1 reference

12 May 2018

Seppo Helisalmi

4

1 reference

12 May 2018

Maarit Lehtovirta

5

1 reference

12 May 2018

Tuomo Hänninen

6

1 reference

12 May 2018

publication date

1 September 2005

1 reference

12 May 2018

European Journal of Human Genetics

published in

1 reference

12 May 2018

volume

13

1 reference

12 May 2018

issue

9

1 reference

12 May 2018

page(s)

1000-1006

1 reference

12 May 2018

The number of trait loci in late-onset Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Results of a high-resolution genome screen of 437 Alzheimer's disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Neuroprotection by estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

The neuroprotective effects of estrogen on the aging brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogens: trophic and protective factors in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Ovarian steroids and the brain: implications for cognition and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Sex steroid control of mood, mental state and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Untangling the human estrogen receptor gene structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Morphological abnormalities in the brains of estrogen receptor beta knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

What pharmacologists can learn from recent advances in estrogen signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

AN EXACT TEST FOR POPULATION DIFFERENTIATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Are the estrogen receptors involved in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

7 January 2021

Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

7 January 2021

Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

7 January 2021

Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5201447

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201447

1 reference

12 May 2018

Dimensions Publication ID

1003102944

0 references

1 reference

12 May 2018